Raia Drogasil S.A.
RADLY
$4.54
-$0.04-0.87%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.87% | 1.68% | -1.68% | -0.29% | 6.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.87% | 1.68% | -1.68% | -0.29% | 6.05% |
| Cost of Revenue | 10.52% | 2.38% | -1.06% | 0.28% | 6.55% |
| Gross Profit | 8.32% | 0.02% | -3.12% | -1.62% | 4.90% |
| SG&A Expenses | 8.02% | 0.73% | -2.94% | -1.21% | 3.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -503.36% | 52.97% | 72.24% | 79.54% | 106.16% |
| Total Operating Expenses | 9.77% | 2.07% | -1.30% | 0.19% | 6.33% |
| Operating Income | 11.33% | -4.21% | -7.32% | -7.45% | 1.87% |
| Income Before Tax | -1.21% | -8.14% | -9.81% | -7.76% | 7.92% |
| Income Tax Expenses | -35.08% | -77.53% | -64.75% | -30.95% | 56.24% |
| Earnings from Continuing Operations | 5.00% | 9.58% | 1.68% | -3.25% | 2.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 76.52% | 44.71% | 57.81% | 79.96% | 65.82% |
| Net Income | 5.82% | 11.04% | 3.37% | -0.92% | 4.20% |
| EBIT | 11.33% | -4.21% | -7.32% | -7.45% | 1.87% |
| EBITDA | 12.38% | -3.24% | -6.21% | -6.75% | 1.52% |
| EPS Basic | 23.03% | 28.36% | 20.85% | -11.68% | -5.87% |
| Normalized Basic EPS | 15.22% | 0.91% | 3.70% | -17.73% | -4.65% |
| EPS Diluted | 22.87% | 28.31% | 20.72% | -11.71% | -5.89% |
| Normalized Diluted EPS | 15.04% | 0.80% | 3.59% | -17.67% | -4.66% |
| Average Basic Shares Outstanding | -17.35% | -16.38% | -16.78% | 16.12% | 15.04% |
| Average Diluted Shares Outstanding | -17.22% | -16.30% | -16.63% | 16.06% | 14.86% |
| Dividend Per Share | 135.24% | -38.79% | 13.10% | -36.43% | -63.74% |
| Payout Ratio | 0.30% | -0.09% | -0.02% | -0.08% | -0.12% |